SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001485003-17-000101
Filing Date
2017-10-18
Accepted
2017-10-17 19:24:23
Documents
1
Period of Report
2017-10-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A ebio-form8xk_amccaberesign.htm 8-K/A 26936
  Complete submission text file 0001485003-17-000101.txt   28094
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36296 | Film No.: 171141617
SIC: 2834 Pharmaceutical Preparations